These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16304200)

  • 1. Antipneumococcal activity of dalbavancin compared to other agents.
    Lin G; Smith K; Ednie LM; Appelbaum PC
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5182-4. PubMed ID: 16304200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipneumococcal activity of LBM415, a new peptide deformylase inhibitor, compared with those of other agents.
    Ednie LM; Pankuch G; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4027-32. PubMed ID: 15388472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens.
    Streit JM; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):307-10. PubMed ID: 15922534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antistaphylococcal activity of dalbavancin, an experimental glycopeptide.
    Lin G; Credito K; Ednie LM; Appelbaum PC
    Antimicrob Agents Chemother; 2005 Feb; 49(2):770-2. PubMed ID: 15673763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of dalbavancin tested against Staphylococcus spp. and beta-hemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United States.
    Biedenbach DJ; Ross JE; Fritsche TR; Sader HS; Jones RN
    J Clin Microbiol; 2007 Mar; 45(3):998-1004. PubMed ID: 17215346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007).
    Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):177-84. PubMed ID: 19249179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of ceftobiprole compared with those of other agents against Staphylococcus aureus strains with different resistotypes by time-kill analysis.
    Lin G; Appelbaum PC
    Diagn Microbiol Infect Dis; 2008 Feb; 60(2):233-5. PubMed ID: 17997257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004).
    Jones RN; Stilwell MG; Sader HS; Fritsche TR; Goldstein BP
    Diagn Microbiol Infect Dis; 2006 Feb; 54(2):149-53. PubMed ID: 16426793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bactericidal activity and resistance development profiling of dalbavancin.
    Goldstein BP; Draghi DC; Sheehan DJ; Hogan P; Sahm DF
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1150-4. PubMed ID: 17220411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipneumococcal activity of AZD2563, a new oxazolidinone, compared with nine other agents.
    Peric M; Lin G; Clark CL; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 2002 Jul; 50(1):95-100. PubMed ID: 12096012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipneumococcal activity of ceftobiprole, a novel broad-spectrum cephalosporin.
    Kosowska K; Hoellman DB; Lin G; Clark C; Credito K; McGhee P; Dewasse B; Bozdogan B; Shapiro S; Appelbaum PC
    Antimicrob Agents Chemother; 2005 May; 49(5):1932-42. PubMed ID: 15855516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 study.
    Karlowsky JA; Adam HJ; Poutanen SM; Hoban DJ; Zhanel GG;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):342-7. PubMed ID: 21353963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal activity of daptomycin against Streptococcus pneumoniae compared with eight other antimicrobials.
    Pankuch GA; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 2003 Feb; 51(2):443-6. PubMed ID: 12562720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dalbavancin Activity When Tested against Streptococcus pneumoniae Isolated in Medical Centers on Six Continents (2011 to 2014).
    Jones RN; Schuchert JE; Mendes RE
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3419-25. PubMed ID: 27001811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
    Kosowska-Shick K; Credito K; Pankuch GA; Lin G; Bozdogan B; McGhee P; Dewasse B; Choi DR; Ryu JM; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2064-71. PubMed ID: 16723567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of dalbavancin against staphylococci and streptococci, assessed by BSAC and NCCLS agar dilution methods.
    Mushtaq S; Warner M; Johnson AP; Livermore DM
    J Antimicrob Chemother; 2004 Sep; 54(3):617-20. PubMed ID: 15321983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of a surrogate agent (vancomycin or teicoplanin) for initial susceptibility testing of dalbavancin: results from an international antimicrobial surveillance program.
    Jones RN; Sader HS; Fritsche TR; Hogan PA; Sheehan DJ
    J Clin Microbiol; 2006 Jul; 44(7):2622-5. PubMed ID: 16825398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo pharmacodynamic activity of the glycopeptide dalbavancin.
    Andes D; Craig WA
    Antimicrob Agents Chemother; 2007 May; 51(5):1633-42. PubMed ID: 17307987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics of dalbavancin studied in an in vitro pharmacokinetic system.
    Bowker KE; Noel AR; MacGowan AP
    J Antimicrob Chemother; 2006 Oct; 58(4):802-5. PubMed ID: 16891629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of dalbavancin against enterococci isolates from wild animals, pets, poultry and humans in Portugal.
    Poeta P; Radhouani H; Sargo R; Igrejas G
    J Basic Microbiol; 2008 Dec; 48(6):526-8. PubMed ID: 18798175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.